Skip to main content
Skip to main content
OPCH logo

Option Care Health, Inc. (OPCH)

$21.64 $-0.26 (-1.19%) |Strong · 76
Bottom line: STRONG BUY — our Council read (76/100) and AI Score (76/100) broadly agree.
MCap: $3.40B| P/E Ratio: 10.0| Vol: 532.9K| Target: $39.00 (+80.2%)|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Option Care Health, Inc. (OPCH) trades at $21.64 with AI Score 76/100 (Grade A). Option Care Health, Inc. is a leading provider of home and alternate site infusion services in the United States. Market cap: $3.40B, Sector: Healthcare.

Price live · AI analysis from May 7, 2026
Option Care Health, Inc. is a leading provider of home and alternate site infusion services in the United States. The company offers a range of therapies and services for various acute and chronic conditions, managing treatments directly in patients' homes or at convenient infusion centers.

OPCH stock analysis for 2026: Analysts have set a consensus price target of $39.00 for Option Care Health, Inc., suggesting 80.2% upside from the current price of $21.64. The AI MoonshotScore is 76/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
STRONG BUY 76/100 · A

OPCH: 1/1 perspectives are bullish.

How is this calculated? →
Council Score · 8 perspectives · See tabs for details →

Option Care Health, Inc. (OPCH) Healthcare & Pipeline Overview

CEOLuke Whitworth
Employees8000
HeadquartersBannockburn, IL, US
IPO Year1996

Option Care Health, Inc. delivers home and alternate site infusion services across the U.S., providing therapies for chronic and acute conditions. With a focus on patient-centered care and a network of infusion centers, Option Care Health addresses the growing demand for accessible and cost-effective healthcare solutions, positioning itself in a competitive healthcare landscape.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 7, 2026

What Is the Investment Thesis for OPCH?

Option Care Health presents a notable research candidate due to its strong market position in the growing home infusion services industry. With a P/E ratio of 10.0 and a profit margin of 3.6%, the company demonstrates solid financial performance. Key growth catalysts include the increasing demand for home-based healthcare services and the expansion of the company's service offerings. The company's established network of infusion centers and focus on patient care provide a competitive advantage. However, potential risks include regulatory changes and competition from other healthcare providers. Investors should monitor the company's ability to maintain its market share and manage costs effectively.

Based on FMP financials and quantitative analysis

OPCH Key Highlights

  • Market Cap of $3.40B reflects substantial investor confidence in Option Care Health's market position and growth potential.
  • P/E Ratio of 10.0 indicates a reasonable valuation relative to earnings, suggesting potential for further appreciation.
  • Gross Margin of 18.0% demonstrates the company's ability to manage costs effectively in the competitive healthcare services market.
  • Profit Margin of 3.6% shows the efficiency of Option Care Health in converting revenue into profit.
  • Beta of 0.95 suggests that the stock is slightly less volatile than the overall market, potentially offering a more stable investment.

Who Are OPCH's Competitors?

OPCH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
IMVT Immunovant, Inc. $38.60 -0.49% $7.92B 57
LNTH Lantheus Holdings, Inc. $102.82 -6.43% 7B 91
OSCR Oscar Health, Inc. $30.84 -4.16% $8.00B 39
AKRO Akero Therapeutics, Inc. $54.65 +0.00% $4.50B 46
INDV Indivior PLC $39.72 -0.20% $4.96B 54
HWAIF Healwell AI Inc. $0.53 -3.52% $160.75M 65
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.35M 63
FTRP Field Trip Health Ltd. $0.84 +1.07% $9.81M 62

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OPCH's Key Strengths?

  • Comprehensive range of infusion therapies and services.
  • Established network of infusion centers and healthcare professionals.
  • Strong relationships with healthcare providers and payers.
  • Commitment to high-quality, patient-centered care.

What Are OPCH's Weaknesses?

  • Reliance on reimbursement from payers.
  • Exposure to regulatory changes and healthcare policy reforms.
  • Competition from other home infusion providers and specialty pharmacies.
  • Potential for service disruptions due to supply chain issues or natural disasters.

What Could Drive OPCH Stock Higher?

  • Expansion of service offerings to include additional therapies and services.
  • Geographic expansion into underserved markets.
  • Strategic partnerships with hospitals and physician groups.
  • Leveraging technological advancements to improve efficiency and patient care.

What Are the Key Risks for OPCH?

  • Increasing competition from other home infusion providers.
  • Changes in reimbursement rates or healthcare policies.
  • Product liability claims or recalls.
  • Economic downturn or recession.
  • Reliance on reimbursement from payers.

What Are the Growth Opportunities for OPCH?

  • Expansion of Service Offerings: Option Care Health has the opportunity to expand its service offerings to include additional therapies and services, such as specialty pharmacy services and chronic disease management programs. This expansion would allow the company to attract new patients and increase revenue from existing patients. The market for specialty pharmacy services is estimated to be worth billions of dollars, providing a significant growth opportunity for Option Care Health. Timeline: Ongoing.
  • Geographic Expansion: Option Care Health can expand its geographic reach by opening new infusion centers in underserved markets and acquiring smaller home infusion providers. This expansion would allow the company to reach more patients and increase its market share. The market for home infusion services is growing rapidly, particularly in rural areas where access to healthcare is limited. Timeline: Ongoing.
  • Strategic Partnerships: Option Care Health can form strategic partnerships with hospitals, physician groups, and other healthcare providers to expand its referral network and gain access to new patients. These partnerships would allow the company to integrate its services into the broader healthcare ecosystem and improve patient outcomes. Many hospitals are looking to partner with home infusion providers to reduce costs and improve patient satisfaction. Timeline: Ongoing.
  • Technological Advancements: Option Care Health can leverage technological advancements, such as telehealth and remote monitoring, to improve the efficiency and effectiveness of its services. These technologies would allow the company to provide more convenient and personalized care to patients. The market for telehealth and remote monitoring is growing rapidly, driven by the increasing adoption of digital health technologies. Timeline: Ongoing.
  • Value-Based Care: Option Care Health can participate in value-based care arrangements with payers, such as Medicare and Medicaid, to demonstrate the value of its services and improve patient outcomes. These arrangements would incentivize the company to provide high-quality, cost-effective care. The shift towards value-based care is accelerating, creating new opportunities for companies like Option Care Health to demonstrate their value. Timeline: Ongoing.

What Opportunities Does OPCH Have?

  • Expansion of service offerings to include additional therapies and services.
  • Geographic expansion into underserved markets.
  • Strategic partnerships with hospitals and physician groups.
  • Leveraging technological advancements to improve efficiency and patient care.

What Threats Does OPCH Face?

  • Increasing competition from other home infusion providers.
  • Changes in reimbursement rates or healthcare policies.
  • Product liability claims or recalls.
  • Economic downturn or recession.

What Are OPCH's Competitive Advantages?

  • Established Network: Option Care Health has an established network of infusion centers and healthcare professionals, providing a competitive advantage in terms of geographic reach and service delivery.
  • Comprehensive Service Offerings: The company offers a comprehensive suite of infusion therapies and related services, allowing it to meet the diverse needs of patients and healthcare providers.
  • Focus on Patient Care: Option Care Health is committed to providing high-quality, patient-centered care, which helps to build trust and loyalty with patients and referral sources.
  • Strong Relationships: Option Care Health has strong relationships with healthcare providers and payers, which helps to ensure a steady stream of referrals and reimbursement for services.

What Does OPCH Do?

Option Care Health, Inc. was formed to address the increasing need for accessible and cost-effective infusion therapy outside of traditional hospital settings. The company provides a comprehensive suite of infusion services, including anti-infective therapies, home parenteral and enteral nutrition, immunoglobulin infusion therapies, and treatments for chronic inflammatory and neurological disorders. These services are delivered either in patients' homes or at the company's network of infusion centers. Since its inception, Option Care Health has focused on expanding its geographic reach and service offerings to meet the diverse needs of patients across the United States. The company has grown through strategic acquisitions and organic growth, enhancing its capabilities and market presence. Option Care Health's commitment to patient care is reflected in its team of healthcare professionals, including nurses, pharmacists, and other specialists, who work closely with patients and their healthcare providers to ensure optimal outcomes. Option Care Health operates in a competitive market, facing competition from other home infusion providers, specialty pharmacies, and hospitals. The company differentiates itself through its comprehensive service offerings, focus on patient care, and established network of infusion centers. Option Care Health continues to invest in technology and infrastructure to improve efficiency and enhance the patient experience.

What Products and Services Does OPCH Offer?

  • Provides anti-infective therapies for patients at home.
  • Offers home infusion services to treat heart failure.
  • Delivers home parenteral and enteral nutrition support.
  • Administers immunoglobulin infusion therapies for immune deficiencies.
  • Treats chronic inflammatory disorders like Crohn's disease and rheumatoid arthritis.
  • Manages neurological disorders such as ALS and muscular dystrophy with infusion therapies.
  • Provides infusion therapies for bleeding disorders.
  • Offers specialized therapies for high-risk pregnancies.

How Does OPCH Make Money?

  • Provides infusion therapies and related services directly to patients in their homes or at alternate sites.
  • Contracts with healthcare providers and payers to receive referrals and reimbursement for services.
  • Generates revenue through a combination of fee-for-service and value-based care arrangements.
  • Manages a network of infusion centers and healthcare professionals to deliver high-quality care.

What Industry Does OPCH Operate In?

Option Care Health operates within the medical care facilities industry, which is experiencing growth due to the increasing demand for home-based healthcare services. The aging population and the rising prevalence of chronic diseases are driving the need for more accessible and cost-effective healthcare solutions. The industry is competitive, with several players offering similar services. Option Care Health differentiates itself through its comprehensive service offerings, focus on patient care, and established network of infusion centers. The market is expected to continue to grow, driven by technological advancements and changing patient preferences.

Who Are OPCH's Key Customers?

  • Patients with acute and chronic conditions requiring infusion therapy.
  • Hospitals and physician groups referring patients for home infusion services.
  • Payers, including insurance companies and government healthcare programs, reimbursing for services.
  • Managed care organizations seeking cost-effective and high-quality infusion therapy solutions.
AI Confidence: 83% Updated: May 7, 2026

Option Care Health, Inc. (OPCH) Valuation Context

Valued at $3.40B, OPCH is classified as a mid-cap stock. Relative to its peer group, OPCH's quantitative score of 76/100 is above the peer average of 57/100.

ROE 15%Key Financial Metrics

Return on equity for Option Care Health, Inc. stands at 15.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.1%, showing how much profit it generates from its asset base. OPCH trades at a trailing price-to-earnings ratio of 9.99, below the Healthcare sector average of ~23x. Its free cash flow yield is 7.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.3%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9Financial Health

Option Care Health, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.57 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project Option Care Health, Inc. revenue of about $5.73B for fiscal 2026, with EPS near $1.84. The estimate reflects 10 contributing analysts.

OPCH Financials

Fundamental Snapshot

Revenue Growth (FY)
+13.0%
Net Income Growth (FY)
-2.0%
EPS Growth (FY)
+4.1%
Free Cash Flow Growth (FY)
-24.5%
P/E (TTM)
16.0
Return on Equity (TTM)
+15.3%
Current Ratio
1.6
EV/EBITDA (TTM)
10.7

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Market sentiment data being refreshed
  • Community discussions being analyzed

Bear Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Risk factors being evaluated
  • Market concerns being processed

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

OPCH Latest News

OPCH Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OPCH.

Price Targets

Consensus target: $39.00

OPCH MoonshotScore

76/100

What does this score mean?

The MoonshotScore rates OPCH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: John C. Rademacher

CEO

John C. Rademacher serves as the CEO of Option Care Health, Inc. He has extensive experience in the healthcare industry, with a proven track record of driving growth and improving operational efficiency. Prior to joining Option Care Health, Rademacher held leadership positions at various healthcare companies, where he was responsible for strategic planning, business development, and financial management. He has demonstrated expertise in managing large teams and navigating complex regulatory environments. Rademacher's background includes a strong focus on patient care and a commitment to delivering high-quality healthcare services.

Track Record: Since becoming CEO, John C. Rademacher has focused on expanding Option Care Health's service offerings and geographic reach. He has overseen the acquisition of several smaller home infusion providers, which has helped to increase the company's market share. Rademacher has also implemented initiatives to improve patient satisfaction and reduce costs. Under his leadership, Option Care Health has achieved significant revenue growth and improved profitability.

OPCH Healthcare Stock FAQ

What does Option Care Health, Inc. do?

Option Care Health, Inc. is a leading provider of home and alternate site infusion services in the United States. The company offers a range of therapies and services for various acute and chronic conditions, including anti-infective therapies, home parenteral and enteral nutrition, immunoglobulin infusion therapies, and treatments for chronic inflammatory and neurological disorders. These services are delivered either in patients' homes or at the company's network of infusion centers. Option Care Health works closely with patients and their healthcare providers to ensure optimal outcomes.

What do analysts say about OPCH stock?

Analyst coverage of Option Care Health, Inc. (OPCH) generally reflects a positive outlook, citing the company's strong market position and growth potential within the home infusion services industry. Key valuation metrics, such as the P/E ratio of 10.0, suggest a reasonable valuation relative to earnings. Growth considerations include the increasing demand for home-based healthcare services and the company's ability to expand its service offerings and geographic reach. Investors should conduct their own due diligence and consider their individual investment objectives before making any investment decisions.

What are the main risks for OPCH?

Option Care Health, Inc. faces several risks, including increasing competition from other home infusion providers and specialty pharmacies. Changes in reimbursement rates or healthcare policies could also negatively impact the company's financial performance. Product liability claims or recalls are another potential risk. Additionally, an economic downturn or recession could reduce demand for the company's services. Investors should carefully consider these risks before investing in Option Care Health, Inc.

How does Option Care Health, Inc. navigate regulatory approval processes?

As a provider of infusion therapies and related services, Option Care Health operates in a highly regulated environment. The company must comply with various federal and state regulations, including those related to drug compounding, dispensing, and administration. Option Care Health works closely with regulatory agencies to ensure compliance and maintain its licenses and accreditations. The company also has a robust quality assurance program to monitor and improve the safety and effectiveness of its services. Staying compliant with evolving healthcare regulations is critical for maintaining operational integrity and market access.

How does Option Care Health, Inc. address the challenges of managing complex patient care in a home setting?

Option Care Health addresses the complexities of home-based patient care through a multidisciplinary approach involving nurses, pharmacists, and other healthcare professionals. The company utilizes technology to monitor patients remotely and ensure timely intervention when needed. Option Care Health also provides education and support to patients and their caregivers to help them manage their conditions effectively. By focusing on patient-centered care and leveraging technology, Option Care Health aims to improve patient outcomes and reduce the risk of complications in the home setting.

What are the key factors to evaluate for OPCH?

Option Care Health, Inc. (OPCH) holds an AI score of 76/100 (high). P/E: 10.0x vs the S&P 500's ~20-25x. Analysts target $39.00 (+80%). Not financial advice.

How frequently does OPCH data refresh on this page?

OPCH prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven OPCH's recent stock price performance?

Option Care Health, Inc. (OPCH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive range of infusion therapies and services. See the News tab for the latest drivers. Past performance does not predict future results.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on available data and may be subject to change.
Data Sources

Popular Stocks